Skip to main content
Veterinary Medicines

PROGRAM Plus

Not authorised
  • Milbemycin oxime
  • Lufenuron

Product identification

Medicine name:
Program plus 11,5 mg + 230 mg comprimidos revestidos para cães
PROGRAM Plus
Active substance:
  • Milbemycin oxime
  • Lufenuron
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    5.75
    milligram(s)
    /
    1.00
    Tablet
  • Lufenuron
    115.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Revoked
Authorised in:
  • Portugal
Package description:
  • Carton container containing 8 pentagonal tablets in PVDC/PVC blisters, thermosealed with aluminium foil, boxed in a free-opening, labelled carton
  • Carton container containing 6 pentagonal tablets in PVDC/PVC blister, thermosealed with aluminium foil, boxed in a free-opening, labelled carton

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 51338
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0106/002

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."